Results 21 to 30 of about 248,209 (312)
Infectious Disease Clinics of North America, 2022 This article is a narrative review of the rapidly moving coronavirus disease 2019 vaccine field with an emphasis on clinical efficacy established in both randomized trials and postmarketing surveillance of clinically available vaccines. We review the major clinical trials that supported authorization for general use of the Janssen (Ad.26.CoV2), Pfizer ...
Hahn, William O., Wiley, Zanthia
openaire +3 more sources
Determinants of COVID-19 Vaccination Intention among Health Care Workers in France: A Qualitative Study [PDF]
, 2022 COVID-19 vaccines are one of the best tools to limit the spread of the virus. However, vaccine hesitancy is increasing worldwide, and France is one of the most hesitant countries.
Angela Baron +14 more
core +2 more sources
Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities—An Agent-Based Modeling Evaluation [PDF]
, 2021 (1) Background: The Austrian supply of COVID-19 vaccine is limited for now. We aim to provide evidence-based guidance to the authorities in order to minimize COVID-19-related hospitalizations and deaths in Austria.
Christiane Druml +21 more
core +1 more source
The Changing Acceptance of COVID-19 Vaccination in Different Epidemic Phases in China: A Longitudinal Study [PDF]
, 2021 COVID-19 vaccines have been conditionally used in a few countries, including China since December 2020. The present study aimed to examine whether the acceptance of COVID-19 vaccination changed in different COVID-19 epidemic phases in China.
Wenzhou Yu +9 more
core +1 more source
Microbial Pathogenesis, 2022 As of 2022, the global population has access to several mRNA and traditional inactivated vaccines. However, their effectiveness in preventing infection, hospitalization, and COVID-associated mortality in Jordan has yet to be evaluated. The purpose of this observational study was to evaluate the relative effectiveness of three approved vaccines against ...
Mohamed J. Saadh, Saif Aldeen Jaber
openaire +2 more sources
COVID-19 Vaccination and The Eye [PDF]
American Journal of Ophthalmology, 2022 To summarize the current evidence on COVID-19 vaccine-associated ocular adverse events.Narrative literature review.The literature search was conducted in August 2021 using 4 electronic databases: MEDLINE, EMBASE, PubMed, and the Cochrane Database of Systematic Reviews.
Michael T.M. Wang +3 more
openaire +2 more sources
The Time for COVID-19 Vaccination
Journal of Virology, 2021 The composition and dynamics of viral mutant spectra in infected individuals advise that to avoid selection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escape mutants, vaccination campaigns for coronavirus disease 2019 (COVID-19) should be launched when disease incidence is low.
Domingo, Esteban, Perales, Celia
openaire +4 more sources
Trust in Vaccination as a Factor in Public Health During a Pandemic [PDF]
Business Ethics and Leadership, 2021 The article summarizes the arguments in the scientific debate on public trust in vaccination against COVID-19. The main purpose of the research is to model the trend of changes in the trust in vaccination against COVID-19, analyzing time series by ...
Olha Kuzmenko, Svitlana Kolomiiets
doaj +1 more source
COVID‐19: vaccine’s progress [PDF]
Microbial Biotechnology, 2021 Summary Under the pressure of the COVID‐19 pandemic, vaccines were developed and rolled out into mass vaccination campaigns at incredible speed. What normally takes a decade was worked out within a year. Vaccines were produced along many different platforms ranging from inactivated whole virus vaccines over adenovirus‐vectored ...
openaire +4 more sources
Subsequent COVID-19 Prophylaxis in COVID-19 Associated Glomerulopathies [PDF]
, 2023 Successful vaccination has been the decisive factor in the overall decline of SARS-CoV2 infection related morbidity and mortality. However, global effects of the COVID-19 pandemic are ongoing, with reports of glomerular disease occurring in relation to ...
Suran L. Fernando +5 more
core +1 more source